TD1 ASX Week ended 31 Jul 2026

Weekly Investor Report

Name: TD1 weekly investor report
Creator: Sharemaestro
License: https://sharemaestro.com/data-license/

TALi Digital Limited · Healthcare · Health Information Services

Open interactive chart View report data

Latest close 0.08 AUD

20.9% latest week

Weekly setup

Constructive, but selective

The weekly trend is active. Price is 42.6% above the Trend Line and sits at 37.3% of its 52-week range. The latest completed week returned 20.9%, after a 30.6% four-week move. The latest factor snapshot indicates quality is middle-of-the-pack; growth is moderate; valuation is neither clearly cheap nor expensive. The latest news-sentiment score is 53/100. Near-term considerations: volume confirmation is below normal.

Setup score 47 out of 100

Latest Close 0.08 AUD 31 Jul 2026

1W Return 20.9% latest completed week

4W Return 30.6% short-term follow-through

12W Return 47.3% quarterly tape

Trend Breadth 11.5% 6 of 52 weeks active

Volume Ratio 0.3x vs 13-week average

What is working

The trend backdrop is active with a 6-week active streak.
Price is above the Trend Line, keeping the weekly tape constructive.
Activity pressure is positive on the latest completed week.
Activity pressure is constructive, supporting the smart-money activity read.

What could go wrong

Price is below Fair Value, so the market is still discounting the latest tape.
Next-week expectancy is negative at 19.58% based on similar historical setup states.
The share remains more than 20% below its 52-week high.
Recent volatility is running well above the one-year baseline.

What to watch next

Trend Line remains the key weekly regime level.
Activity pressure is the gauge to monitor for confirmation or fade.
A volume ratio above 1.5x would show stronger participation in the next move.

Price follow-through 20.9% Latest completed week; four-week move 30.6%. Indicator stack 27/56 Trend and activity pressure are weighted against the latest 12-week confirmation window. Trend backdrop Active The trend backdrop defines the current weekly regime. Patient Capital Quiet Activity-pressure buy-signal status for institutional accumulation timing. Next-Week Expectancy Negative 19.58% Historical one-week expectancy contributes to the evidence score when direction is confirmed. News sentiment 53/100 16 relevant articles in the latest sentiment read.

01 · Price action

Where price is—and whether the trend supports it

The weekly trend is active. Price is 42.6% above the Trend Line and sits at 37.3% of its 52-week range. The latest completed week returned 20.9%, after a 30.6% four-week move.

Study the full chart

52-week price path

Price vs Trend Line and Fair Value

Price Trend Line Fair Value

Position in the 52-week range

Close Trend Fair

0.04 AUD 37.3% 0.15 AUD

Range location37.3%Shows where the latest close sits between the 52-week low and high.

Trend distance42.6%Price premium or discount versus the weekly Trend Line.

Fair-value gap-21.8%Premium demand or model discount versus Sharemaestro Fair Value.

High-water gap-46.0%Distance from the latest 52-week high.

02 · Volume and demand

Is real participation confirming the move?

Latest weekly volume is 0.3x the 13-week average. Participation is below its recent norm, so price strength is not receiving full volume confirmation.

26-week volume confirmation

Bar height shows volume; colour shows the weekly price direction

6 Feb 13 Feb 20 Feb 27 Feb 6 Mar 13 Mar 20 Mar 27 Mar 3 Apr 10 Apr 17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun 19 Jun 26 Jun 3 Jul 10 Jul 17 Jul 24 Jul 31 Jul

Up week Down week

Demand beneath price

Activity pressure and institutional-style signals

These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.

Activity pressure path

Latest 0.6312-week average 0.39

12-week confirmation

Trend active6/12Active trend-backdrop weeks in the latest 12-week window.

Positive pressure12/12Weeks with constructive activity pressure in the latest 12-week window.

Positive leadership3/12Weeks with positive relative leadership in the latest 12-week window.

Activity pressure0.63Current proprietary activity-pressure read.

Buy signals1Accumulation signal count in the latest 12 weeks.

Reversal markers0No reversal markers

No recent accumulation markers. No reversal markers.

03 · Momentum and leadership

Is performance persistent—and is the stock leading?

Performance is 30.6% over four weeks, 47.3% over 12 weeks, and -19.0% over one year. The current trend has remained active for 6 consecutive weeks.

Performance by holding period

1W20.9%

4W30.6%

12W47.3%

26W44.6%

52W-19.0%

Active trend streak6 weeks

Active weeks in one year6

Trend breadth11.5%

Activity pressure vs relative leadership

Activity pressureRelative leadership

Pressure0.59Latest activity-pressure read.

Pressure change-52.4%Four-week change in activity pressure.

Leadership11.15Latest relative-leadership reading.

RS change167.1%Four-week change in relative leadership.

04 · Fundamentals and valuation

What investors are paying for—and the quality behind it

The latest factor snapshot indicates quality is middle-of-the-pack; growth is moderate; valuation is neither clearly cheap nor expensive.

Open full factor analysis

Factor week 26 Jul 2026 Financial statements through 30 Jun 2025 Field coverage 67% Model confidence 36%

Relative factor standing

Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.

Overall factor strength13/100Blend of value, momentum, and quality. Underlying universe rank 88; rank 1 is best.

Value26/100Relative valuation strength. Underlying universe rank 75; rank 1 is best.

Quality24/100Profitability and accounting quality. Underlying universe rank 77; rank 1 is best.

Momentum26/100Medium-term price momentum. Underlying universe rank 75; rank 1 is best.

Growth26/100Revenue and earnings growth. Underlying universe rank 75; rank 1 is best.

How to read this

Quality and valuation are separate questions

A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.

Valuation

How much investors are paying for earnings, sales, and cash flow.

P/E: -
Price / sales: 2639.7x
EV / EBITDA: -
Free-cash-flow yield: -25.7%

Business quality

Margins and the return generated on invested capital.

Gross margin: 100.0%
Operating margin: -59973.9%
Free-cash-flow margin: -39865.6%
Return on invested capital: -

Growth and financial strength

Recent business growth and accounting strength.

Revenue growth: -
EPS growth: -
Free-cash-flow growth: -
Piotroski F-score: 2/9

Shareholder return and balance sheet

Cash returned to owners and financial leverage.

Dividend yield: -
Buyback yield: -23.9%
Shareholder yield: -23.9%
Net debt / EBITDA: 1.8x

05 · Ownership, options, and sentiment

What other market participants are doing

Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.

Insider activity-

No recent insider transactions are stored for this company.

News sentiment53/100

Weighted news tone is neutral across 16 relevant articles.

2 positive · 14 neutral · 0 negative

Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal

06 · Catalysts and risk

What can move the shares—and how volatile the path has been

Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.

Next earnings-No event is currently stored.

Options expected move-Nearest-chain priced movement where available.

52-week drawdown-46.0%Distance below the 52-week high.

13-week volatility18.1%Standard deviation of weekly returns.

Weekly gains and losses

Latest 26 completed weeks

Each bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.

6 Feb 6 Mar 3 Apr 1 May 29 May 26 Jun 31 Jul

Weeks higher13 of 2611 weeks finished lower.

Best week+40.0%Week of 19 Jun.

Worst week-23.8%Week of 26 Jun.

Latest week+20.9%Week of 31 Jul.

Shape of recent returns

Strong gains9

Modest gains4

Flat weeks2

Modest losses3

Sharp losses8

Recent vol18.1%13-week weekly-return volatility.

Base vol11.6%52-week weekly-return volatility.

Up/down split16/17Count of positive and negative weeks in the 52-week window.

Average skew11.7% / -10.2%Average positive week versus average negative week.

07 · Sector and peer context

Is this stock leading—or simply moving with its group?

Sector and industry breadth distinguish company-specific strength from a broad group move.

SectorAU Healthcare

4-week rank- / 100

Group average-5.0%

Trend breadth23.0%

Trend23.0%active weekly trend signals

MD60.0%positive activity pressure

RS24.0%positive relative leadership

Four-week leaders

RHT · ASX45.5%AFP · ASX36.2%TTX · ASX27.4%PTX · ASX25.0%EYE · ASX23.8%

IndustryAU Health Information Services

4-week rank2 / 25

Group average-6.4%

Trend breadth32.0%

Trend32.0%active weekly trend signals

MD64.0%positive activity pressure

RS28.0%positive relative leadership

Four-week leaders

RHT · ASX45.5%TD1 · ASX30.6%AHE · ASX28.6%EMD · ASX14.6%GLH · ASX8.3%

08 · Evidence and weekly data

The underlying research record

Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.

Weekly tape41/100

Trend, activity pressure, participation, and risk combine to a 41/100 tape read.

Indicator analysis58/100

Latest 12-week confirmation: trend 6/12, activity pressure 12/12, relative leadership 3/12.

Activity pressure 0.63; No reversal markers Next-Week ExpectancyNegative 19.58%

Next-week expectancy is negative with a 19.58% historical one-week setup read.

Adds short-term historical context without overriding trend, activity, or relative leadership. Factors21/100

O'Shaughnessy factor stack blends value, quality, momentum, and confidence.

Buyback Yield rank 91 Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal Sentiment53/100

Weighted news tone is neutral across 16 relevant articles.

TALi Digital Targets AI-Driven Growth as YCDI! Platform Migration Supports Stable Q4 Insiders50/100

No recent insider transaction evidence is stored.

Earnings50/100

No stored earnings event is currently attached to this ticker.

Week	Close	Return	Trend Line	Fair Value	Pressure	Leadership	Volume	Trend
31 Jul 2026	0.08 AUD	20.9%	0.06 AUD	0.10 AUD	0.59	11.15	39.0K	On
24 Jul 2026	0.07 AUD	1.5%	0.06 AUD	0.10 AUD	0.58	-6.48	64.7K	On
17 Jul 2026	0.07 AUD	6.5%	0.06 AUD	0.10 AUD	0.79	-8.97	2.7K	On
10 Jul 2026	0.06 AUD	0.0%	0.06 AUD	0.10 AUD	1.03	-15.35	31.0K	On
3 Jul 2026	0.06 AUD	-22.5%	0.06 AUD	0.10 AUD	1.24	-16.60	16.4K	On
26 Jun 2026	0.08 AUD	-23.8%	0.06 AUD	0.10 AUD	1.46	7.46	4.4K	On
19 Jun 2026	0.10 AUD	40.0%	0.06 AUD	0.11 AUD	1.40	39.18	50	Off
12 Jun 2026	0.07 AUD	7.1%	0.06 AUD	0.11 AUD	1.29	-0.27	23.8K	Off
5 Jun 2026	0.07 AUD	22.8%	0.06 AUD	0.11 AUD	1.16	-5.67	1.1M	Off
29 May 2026	0.06 AUD	11.8%	0.06 AUD	0.11 AUD	0.98	-24.73	210	Off
22 May 2026	0.05 AUD	-1.9%	0.06 AUD	0.11 AUD	0.72	-32.87	226.7K	Off
15 May 2026	0.05 AUD	-5.5%	0.06 AUD	0.11 AUD	0.54	-32.25	60.5K	Off
8 May 2026	0.06 AUD	31.0%	0.06 AUD	0.11 AUD	0.36	-30.17	275.3K	Off
1 May 2026	0.04 AUD	-7.7%	0.06 AUD	0.11 AUD	0.15	-47.24	20.9K	Off

How to use this report

This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.